Abstract:O53* Aims: Dendritic cells (DCs) are major regulators of both T cell and B cell immune responses. While we have previously demonstrated that Th2 cytokines are detrimental and Th1 cytokines are beneficial to xenograft survival (Nature Medicine 2000), the immunological factors controlling cytokine profiles of anti-xeno responses remain unknown. We previously reported that CD11c+CD8α+ cells (DC1-like) were predominant in C57BL/6 recipients, in which Lewis heart grafts were slowly rejected with typical cell-mediated rejection (CMR) in 21 days. In contrast, CD11c+CD8α −(DC2-like) were predominant in BALB/c mice, in which the Lewis heart grafts were rapidly rejected with typical acute vascular rejection (AVR) in 6 days. These data suggest that DCs may play an important role in navigating xenograft immune responses. The present study was undertaken to elucidate the role of distinct subsets of DCs in controlling xenograft rejection. Methods: Purified CD8α+ or CD8α− DCs isolated from wild type (WT) BALB/c, WT C57BL/6 and IL-12−/−C57BL/6 mice were adoptively transferred into syngenic BALB/c and IL-12−/− or WT C57BL/6 mice, and recipients subsequently received Lewis rat heart grafts heterotopically 2 days after DC transfer. Intragraft cytokine expression and serum levels of anti-donor antibodies were measured by RT-PCR and flow cytometry, respectively. Results: Adoptive transfer of CD8α+ DCs into BALB/c mice shifted the immune response to Th1 with increased ratios of IFN-γ/IL-4 and IL-12/IL-4 mRNA in the grafts, and increased level of Th1 mediated anti-donor IgG2a in the circulation, thereby altering the pattern of rejection from AVR to CMR and significantly prolonging xenograft survival to 14.2 ± 0.8 days, while transfer of CD8α − DCs did not change the pattern of rejection and the grafts were rejected at 6 days. In addition, transfer of exogenous CD8α+ DCs rather than CD8α − DCs from WT C57BL/6 mice into IL-12−/− C57BL/6 mice prevented AVR and prolonged xenograft survival to 16.4 ± 0.9 days, while IL-12−/− C57BL/6 mice without transfer rapidly rejected the xenografts with AVR in 6 days. Furthermore, adoptive transfer of CD8α − DCs from IL-12−/− mice into WT C57BL/6 recipients shifted the immune response to Th2 with decreased ratios of intragraft IFN-γ/IL-4 and IL-12/IL-4 mRNA, but increased level of Th2 mediated anti-donor IgG1, thereby altering the pattern of rejection from CMR to AVR and the grafts were rapidly rejected in 9.5 ± 0.6 days. Conclusions: Transfer of CD8α+ DCs (DC1-like) induces Th1-mediated CMR and prolongs xenograft survival, whereas administration of CD8α − DCs (DC2-like) facilitates Th2-mediated AVR and accelerates xenograft rejection. These data suggest that distinct DC subclasses differentially affect the mechanism of xenograft rejection and ultimately affect graft survival.

IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.

Alteration Of Innate Immunity By Donor Il-6 Deficiency In A Presensitized Heart Transplant Model

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Tolerance Induced by IL-6 Deficient Donor Heart is Significantly Involved in Myeloid-Derived Suppressor Cells (Mdscs).

TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.

Pronged Graft Survival by IL-6 Deficient Donor is Significantly Involved in Myeloid-Derived Suppressor Cells (MDSCs)

CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

TGF-β 1 gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo

Effective Induction of Immune Tolerance by Portal Venous Infusion with IL-10 Gene-Modified Immature Dendritic Cells Leading to Prolongation of Allograft Survival

Interleukin-10 Modified Dendritic Cells Induce Allo-Hyporesponsiveness and Prolong Small Intestine Allograft Survival

Adoptive Transfer of Specific Subsets of Dendritic Cells Changes the Xenograft Survival and Pattern of Rejection in A Rat-To-Mouse Cardiac Transplantation Model.

Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice

IMMUNE MODULATION AND PREVENTION OF ALLOGENEIC GRAFT REJECTION BY THERAPEUTIC DENDRITIC CELLS:

IL-17 Promotes Type 1 T Cell Response Through Modulating Dendritic Cell Function in Acute Allograft Rejection.

Distinct Subsets of Dendritic Cells Regulate the Pattern of Acute Xenograft Rejection and Susceptibility to Cyclosporine Therapy.

Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with Nf-Kappa B Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding Ctla4-Ig

Regulatory Dendritic Cells Treatment Induce Donor-Specific Allograft Hyporesponsiveness

High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response

Retinoic acid-inducible gene-1 knockdown induces immature properties in dendritic cells and prolongs the survival time of allograft mice

Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.